Streetbeat News

Stock Prices

AME

AMETEK (NYSE:AME) has outperformed the market over the past 5 years, producing an average annual return of 15.38%. If an investor had bought $1000 of AME stock 5 years ago, it would be worth $2,091.09 today. The company currently has a market capitalization of $36.67 billion.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:30 pm

SPY

UNG

The USA Natural Gas Storage reported a 16B figure, which is lower than the estimated 19B and the prior figure of 41B.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 2:30 pm

INMD

InMode Ltd (NASDAQ:INMD) reported Q2 sales of $136.1 million, a 20% Y/Y increase, beating the consensus of $132 million. Adjusted EPS reached $0.72, compared to $0.59 a year ago, beating the consensus of $0.64. The company expects FY23 sales of $530 million-$540 million compared to the consensus of $533.1 million. INMD shares are up 6.04% at $47.82.

Portfolio Pulse from Vandana Singh

July 27, 2023 | 2:30 pm

FXE

The European Central Bank (ECB) has increased its key interest rates by 25 basis points, marking the ninth consecutive rate hike over the past year. The ECB deposit rate rose to 3.75%, the highest level since April 2001, and the interest rate on main refinancing operations rose to 4.25%, the highest since October 2008. The ECB also decided to cut the remuneration on minimum bank reserves to 0%. The euro fell in reaction to the ECB meeting, with the Invesco CurrencyShares Euro Currency Trust (NYSE:FXE) also dropping by 0.8%.

Portfolio Pulse from Piero Cingari

July 27, 2023 | 2:28 pm

FEMY

Femasys announced that the United States Patent and Trademark Office issued a Notice of Allowance for FemBloc, a permanent birth control solution. This news has led to an increase in Femasys' stock price.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 2:27 pm

URGN

Shares of UroGen Pharma (URGN) were halted on a circuit breaker due to a sharp downside movement. However, the stock is now up by 44.8%.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 2:26 pm

URGN

Trading of UroGen Pharma shares has resumed.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 2:25 pm

ABBV

AbbVie's shares are trading higher following the company's strong Q2 results and an increase in its FY23 guidance.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 2:25 pm

EW

Edwards Lifesciences reported a decrease in its adjusted gross profit margin to 77.7% in Q2, down from 80.5% last year, leading to a drop in its share price.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 2:24 pm

FEMY

Trading of Femasys Inc. shares has resumed.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 2:20 pm